pentetic acid has been researched along with Thalassemias in 18 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SMITH, RS | 1 |
| WEINER, M | 1 |
| Cerami, A | 2 |
| Grady, RW | 1 |
| Peterson, CM | 1 |
| Bhargava, KK | 1 |
| Ridley, CM | 1 |
| Arcasoy, A | 1 |
| Dogru, U | 1 |
| Cavdar, AO | 1 |
| Graziano, JH | 1 |
| Hershko, C | 2 |
| Graham, G | 1 |
| Bates, GW | 1 |
| Rachmilewitz, EA | 1 |
| Vullo, C | 1 |
| Di Palma, A | 1 |
| De Sanctis, V | 1 |
| Borgatti, L | 1 |
| Atti, G | 1 |
| Wonke, B | 1 |
| Hoffbrand, AV | 1 |
| Aldouri, M | 1 |
| Wickens, D | 1 |
| Flynn, D | 1 |
| Stearns, M | 1 |
| Warner, P | 1 |
| Pippard, MJ | 2 |
| Jackson, MJ | 2 |
| Modell, CB | 2 |
| Hoffman, K | 1 |
| Petrou, M | 1 |
| Beard, ME | 1 |
| Necheles, TF | 1 |
| Allen, DM | 1 |
| Constantoulakis, M | 1 |
| Economidou, J | 1 |
| Karagiorga, M | 1 |
| Katsantoni, A | 1 |
| Gyftaki, E | 1 |
| Barry, M | 1 |
| Flynn, DM | 1 |
| Letsky, EA | 1 |
| Risdon, RA | 1 |
| Stockman, JA | 1 |
| Oski, FA | 1 |
| Waxman, HS | 1 |
| Brown, EB | 1 |
| McDonald, R | 1 |
4 reviews available for pentetic acid and Thalassemias
| Article | Year |
|---|---|
Clinical management of thalassemia. The status of new iron chelators.
Topics: Animals; Chelating Agents; Chemical Phenomena; Chemistry; Cholic Acids; Deferoxamine; Drug Evaluatio | 1980 |
Chelation therapy for the treatment of thalassemia.
Topics: Chelating Agents; Deferoxamine; Humans; Hydroxamic Acids; Hydroxybenzoates; Pentetic Acid; Rhodotoru | 1977 |
[Iron-chelating treatment].
Topics: Chelation Therapy; Deferiprone; Deferoxamine; Erythropoiesis; Hemosiderosis; Humans; Iron; Iron Chel | 1989 |
Clinical usefulness of iron chelating agents.
Topics: Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Hemochromatosis; Humans; Iron; Iron Chelat | 1969 |
1 trial available for pentetic acid and Thalassemias
| Article | Year |
|---|---|
Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress.
Topics: Biopsy; Blood Transfusion; Chelating Agents; Child; Deferoxamine; Diethylamines; Female; Humans; Iro | 1974 |
13 other studies available for pentetic acid and Thalassemias
| Article | Year |
|---|---|
CHELATING AGENTS IN THE DIAGNOSIS AND TREATMENT OF IRON OVERLOAD IN THALASSEMIA.
Topics: Adolescent; Blood Transfusion; Chelating Agents; Child; Deferoxamine; Diagnosis; Drug Therapy; Human | 1964 |
FACTORS INFLUENCING THE CLINICAL USE OF CHELATES IN IRON STORAGE DISEASE.
Topics: Calcium; Chelating Agents; Chloramphenicol; Drug Therapy; Edetic Acid; Humans; Iron; Lymphoma, Non-H | 1964 |
Zinc deficiency developing in treatment for thalassaemia.
Topics: Child; Deferoxamine; Humans; Male; Pentetic Acid; Thalassemia; Transfusion Reaction; Zinc | 1982 |
Zinc deficiency in beta-thalassaemia.
Topics: Child; Humans; Pentetic Acid; Thalassemia; Zinc | 1982 |
Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity.
Topics: Adolescent; Adult; Blood Transfusion; Child; Chromatography, Ion Exchange; Electrophoresis, Polyacry | 1978 |
Pathogenesis and management of iron overload in thalassemia.
Topics: Deferoxamine; Hemochromatosis; Humans; Iron; Pentetic Acid; Thalassemia | 1975 |
Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA.
Topics: Adolescent; Adult; Audiometry; Blood Transfusion; Child; Child, Preschool; Deferoxamine; Female; Fer | 1989 |
Subcutaneous diethylene triamine pentaacetic acid: comparison with desferrioxamine in thalassemic patients with iron overload.
Topics: Adult; Child; Deferoxamine; Female; Humans; Infusions, Parenteral; Iron; Male; Pentetic Acid; Thalas | 1988 |
Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA).
Topics: Administration, Oral; Adult; Ascorbic Acid; Child; Deferoxamine; Dose-Response Relationship, Drug; D | 1986 |
Clinical experience with intensive transfusion therapy in Cooley's anemia.
Topics: 17-Ketosteroids; Blood Transfusion; Bone Development; Calcium; Child; Deferoxamine; Electrocardiogra | 1969 |
Combined long-term treatment of hemosiderosis with desferioxamine and DTPA in homozygous beta-thalassemia.
Topics: Adolescent; Adult; Blood Transfusion; Child; Deferoxamine; Drug Therapy, Combination; Erythrocytes; | 1974 |
Editorial: Thalassemia major: a problem of iron overload.
Topics: Ascorbic Acid; Chelating Agents; Child; Child, Preschool; Deferoxamine; Humans; Intestinal Absorptio | 1974 |
Deferoxamine and diethylenetriaminepentaacetic acid (DTPA) in thalassemia.
Topics: Child; Deferoxamine; Female; Humans; Infant; Iron; Male; Pentetic Acid; Thalassemia | 1966 |